CERS - Cerus Corp

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.6 0.0 (0.0%) --- --- --- 0.0 (0.0%) -0.01 (-0.62%) 0.0 (0.0%) 0.0 (0.0%)

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Category: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.03
Diluted EPS:
-0.03
Basic P/E:
-53.3333
Diluted P/E:
-53.3333
RSI(14) 1m:
100.0
VWAP:
1.6
RVol:

Events

Period Kind Movement Occurred At

Related News